Studies on the unique properties of resistant starch and chito-oligosaccharide complexes for reducing high-fat diet-induced obesity and dyslipidemia in rats

Journal of Functional Foods

Volumn 38, Issue , 2017, Pages 20-27

  Shang, Wenting ^a   Si, Xu ^a   Zhou, Zhongkai ^a,b   Wang, Junxuan ^a   Strappe, Padraig ^c   Blanchard, Chris ^b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

^c CENTRAL QUEENSLAND UNIVERSITY   (Australia)

Author keywords

Chito oligosaccharide; Lipid metabolism; Obesity; PPAR pathway; Resistant starch

Indexed keywords

EID: 85028696093     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.08.032     Document Type: Article

References (53)

1. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate – A practial and powerful approach to mulpitle testing. Journal of the Royal Statistical Society 57 (1995), 289–300.
2. Bodinham, C.L., Frost, G.S., Robertson, M.D., Acute ingestion of resistant starch reduces food intake in healthy adults. British Journal of Nutrition 103 (2010), 917–922.
3. Chiu, C.Y., Chan, I.L., Yang, T.H., Liu, S.H., Chiang, M.T., Supplementation of chitosan alleviates high-fat diet-enhanced lipogenesis in rats via adenosine monophosphate (AMP)-activated protein kinase activation and inhibition of lipogenesis-associated Genes. Journal of Agricultural & Food Chemistry 63 (2015), 2979–2988.
4. Chiu, Y.T., Stewart, M.L., Effect of variety and cooking method on resistant starch content of white rice and subsequent postprandial glucose response and appetite in humans. Asia Pacific Journal of Clinical Nutrition 22 (2013), 372–379.
5. Cordain, L., Eaton, S.B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B.A., Brand-Miller, J., Origins and evolution of the Western diet: Health implications for the 21st century. American Journal of Clinical Nutrition, 81, 2005, 341.
6. Deuchi, K., Kanauchi, O., Imasato, Y., Kobayashi, E., Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet. Bioscience, Biotechnology, and Biochemistry 59 (1995), 781–785.
7. Eam, D., Jmm, K.W., Both raw and retrograded starch decrease serum triacylglycerol concentration and fat accretion in the rat. British Journal of Nutrition 73 (1995), 287–298.
8. Edmunds, R.C., Mcintyre, J.K., Luckenbach, J.A., Baldwin, D.H., Incardona, J.P., Toward enhanced MIQE compliance: Reference residual normalization of qPCR gene expression data. Journal of Biomolecular Techniques JBT 25 (2014), 54–60.
9. Egras, A.M., Hamilton, W.R., Lenz, T.L., Monaghan, M.S., An evidence-based review of fat modifying supplemental weight loss products. Journal of Obesity 2011 (2010), 1259–1267.
10. Elsaid, N., Jackson, T.L., Gunic, M., Somavarapu, S., Positively charged amphiphilic chitosan derivative for the transscleral delivery of rapamycin. Investigative Ophthalmology & Visual Science, 53, 2012, 8105.
11. Engelking, L.J., Kuriyama, H., Hammer, R.E., Horton, J.D., Brown, M.S., Goldstein, J.L., Liang, G., Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. Journal of Clinical Investigation 113 (2004), 1168–1175.
12. Englyst, H.N., Kingman, S.M., Cummings, J.H., Classification and measurement of nutritionally important starch fractions. European Journal of Clinical Nutrition, 46(Suppl 2), 1992, S33.
13. Fernandes, J.C., Sereno, J., Garrido, P., Parada, B., Cunha, M.F., Reis, F., Santossilva, A., Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model. Marine Drugs 10 (2012), 2661–2675.
14. Gades, M.D., Stern, J.S., Chitosan supplementation and fecal fat excretion in men. Obesity Research 11 (2003), 683–688.
15. Haub, M.D., Hubach, K.L., Al-Tamimi, E.K., Sammy, O., Seib, P.A., Different types of resistant starch elicit different glucose responses in humans. Journal of Nutrition and Metabolism, 2010, 230501.
16. Holland, W.L., Bikman, B.T., Wang, L.P., Guan, Y., Sargent, K.M., Bulchand, S., Wenk, M.R., Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. Journal of Clinical Investigation 121 (2011), 1858–1870.
17. Huang, L., Chen, J., Cao, P., Pan, H., Ding, C., Xiao, T., Su, Z., Anti-obese effect of glucosamine and chitosan oligosaccharide in high-fat diet-induced obese rats. Marine Drugs 13 (2015), 2732–2756.
18. Johnston, K.L., Thomas, E.L., Bell, J.D., Frost, G.S., Robertson, M.D., Resistant starch improves insulin sensitivity in metabolic syndrome. Diabetic Medicine 27 (2010), 391–397.
19. Ju, C., Yue, W., Yang, Z., Zhang, Q., Antidiabetic effect and mechanism of chitooligosaccharides. Biological & Pharmaceutical Bulletin 33 (2010), 1511–1516.
20. Kenny, P.J., Common cellular and molecular mechanisms in obesity and drug addiction. Nature Reviews Neuroscience 12 (2011), 638–651.
21. Kim, J.N., Chang, I.Y., Kim, H.I., Yoon, S.P., Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic rats. Islets 1 (2009), 111–116.
22. Kim, W.K., Chung, M.K., Kang, N.E., Kim, M.H., Park, O.J., Effect of resistant starch from corn or rice on glucose control, colonic events, and blood lipid concentrations in streptozotocin-induced diabetic rats. Journal of Nutritional Biochemistry 14 (2003), 166–172.
23. Kishida, T., Nogami, H., Himeno, S., Ebihara, K., Heat moisture treatment of high amylose cornstarch increases its resistant starch content but not its physiologic effects in rats. The Journal of Nutrition 131 (2001), 2716–2721.
24. Kota, S., Kota, S., Meher, L., Modi, K., Rao, E.S., Krishna, S.V.S., Jammula, S., Nutraceuticals in pathogenic obesity; striking the right balance between energy imbalance and inflammation. Journal of Medical Nutrition & Nutraceuticals, 1, 2012, 63.
25. Leclercq, I.A., Silva Morais, A.D., Schroyen, B., Van Hul, N., Geerts, A., Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. Journal of Hepatology 47 (2007), 142–156.
26. Li, J., Takaishi, K., Cook, W., Mccorkle, S.K., Unger, R.H., Insig-1 “brakes” lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proceedings of the National Academy of Sciences 100 (2003), 9476–9481.
27. −△△CT Method. Methods 25 (2001), 402–408.
28. Ma, Z., Boye, J.I., Research advances on structural characterization of resistant starch and its structure-physiological function relationship: A review. Critical Reviews in Food Science & Nutrition, 2016.
29. Maki, K.C., Pelkman, C.L., Finocchiaro, E.T., Kelley, K.M., Lawless, A.L., Schild, A.L., Rains, T.M., Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. Journal of Nutrition 142 (2012), 717–723.
30. Muanprasat, C., Chatsudthipong, V., Chitosan oligosaccharide: Biological activities and potential therapeutic applications. Pharmacology & Therapeutics 170 (2017), 80–97.
31. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Abbafati, C., Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: A systematic analysis. Lancet 384 (2014), 766–781.
32. Niu, J., Lin, H.Z., Jiang, S.G., Chen, X., Wu, K.C., Liu, Y.J., Tian, L.X., Comparison of effect of chitin, chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine on growth performance, antioxidant defenses and oxidative stress status of Penaeus monodon. Aquaculture 372–375 (2013), 1–8.
33. Park, P.J., Je, J.Y., Kim, S.K., Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. Journal of Agricultural & Food Chemistry 51 (2003), 4624–4627.
34. Patra, S., Nithya, S., Review of medicinal plants for anti-obesity activity. Translational Biomedicine, 6, 2015.
35. Robertson, M.D., Bickerton, A.S., Dennis, A.L., Vidal, H., Frayn, K.N., Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. American Journal of Clinical Nutrition 82 (2005), 559–567.
36. Robertson, M.D., Currie, J.M., Morgan, L.M., Jewell, D.P., Frayn, K.N., Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46 (2003), 659–665.
37. Rodgers, R.J., Tschöp, M.H., Wilding, J.P., Anti-obesity drugs: Past, present and future. Disease Models & Mechanisms 5 (2012), 621–626.
38. Schulz, M.D., Atay, Ç., Heringer, J., Romrig, F.K., Schwitalla, S., Aydin, B., Pommerenke, C., High-fat diet-mediated dysbiosis promotes intestinal carcinogenesis independent of obesity. Nature 514 (2014), 508–512.
39. Siersbæk, R., Nielsen, R., Mandrup, S., PPARγ in adipocyte differentiation and metabolism-novel insights from genome-wide studies. Febs Letters 584 (2010), 3242–3249.
40. Souza, M.R., Diniz, M.F., Medeiros-Filho, J.E., Araújo, M.S., Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arquivos De Gastroenterologia, 49, 2012, 89.
41. Sumiyoshi, M., Kimura, Y., Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. The Journal of Pharmacy and Pharmacology, 58, 2006, 201.
42. Vandevijvere, S., Chow, C.C., Hall, K.D., Umali, E., Swinburn, B.A., Increased food energy supply as a major driver of the obesity epidemic: A global analysis. Bulletin of The World Health Organization 93 (2015), 446–456.
43. Walsh, A.M., Sweeney, T., Bahar, B., Flynn, B., O'Doherty, J.V., The effect of chitooligosaccharide supplementation on intestinal morphology, selected microbial populations, volatile fatty acid concentrations and immune gene expression in the weaned pig. Animal 6 (2012), 1620–1626.
44. Wang, J. X., Si, X., Shang, W. T., Zhou, Z. K., Strappe, P., & Blanchard, C. (2016). Effect of single or combined administration of resistant starch and chitosan oligosaccharides on insulin resistance in rats fed with a high-fat diet. Starch – Starke.
45. Wydro, P., Krajewska, B., HaC-Wydro, K., Chitosan as a lipid binder: A langmuir monolayer study of chitosan-lipid interactions. Biomacromolecules 8 (2007), 2611–2617.
46. Yang, T., Espenshade, P.J., Wright, M.E., Yabe, D., Gong, Y., Aebersord, R., Brown, M.S., Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110 (2002), 489–500.
47. Yang, Y., Liu, W.S., Han, B.Q., Liu, B., Fu, C.W., Protective effects of chitosan oligosaccharide and its derivatives against carbon tetrachloride-induced liver damage in mice. Hepatology Research 35 (2006), 178–184.
48. Ykijärvinen, H., Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes & Endocrinology, 2, 2014, 901.
49. Younes, I., Rinaudo, M., Chitin and chitosan preparation from marine sources. Structure, properties and applications. Marine Drugs 13 (2015), 1133–1174.
50. Zeidan, Y.H., Hannun, Y.A., Translational aspects of sphingolipid metabolism. Trends in Molecular Medicine 13 (2007), 327–336.
51. Zeng, L.T., Qin, C.Q., Wang, W., Chi, W.L., Li, W., Absorption and distribution of chitosan in mice after oral administration. Carbohydrate Polymers 71 (2008), 435–440.
52. Zhang, J.L., Liu, J.N., Li, L., Xia, W.S., Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets. Nutrition Research 28 (2008), 383–390.
53. Zhang, Y., Zeng, H.L., Wang, Y., Zeng, S.X., Zheng, B.D., Structural characteristics and crystalline properties of lotus seed resistant starch and its prebiotic effects. Chemical Reviews 114 (2014), 311–318.